Audio-visual entrainment

Domain IX · Biomedical, neuro & digital · Dave Siever · 1984 · Edmonton, Canada

What it is

What it is. AVE presents rhythmic flashes of light (through closed eyelids, via LED glasses) and pulsed tones (through headphones) at a chosen rate. Siever traces it from 19th-century flicker reports (he cites Pierre Janet), Adrian and Matthews' 1934 demonstration that flicker can "drive" the EEG…

Format

• AVE is a device-delivered method rather than a psychotherapy. The developer documentation gives a simple session sequence rather than a phased treatment model; the clinical phases below wrap that sequence in standard psychotherapeutic care. Mind Alive's manual, in the parts cited, does not…
• Screening and decision (1 session, may be within routine assessment). Goal: decide whether AVE is safe and appropriate, or whether the client should be steered away from it. Covers seizure and photosensitivity history, brain injury, psychiatric diagnoses, medicines and recreational drugs or…

Who practises it, and how they are trained or regulated

• Integration with therapy goals. Goal: use any relaxation or altered state as one tool within an established therapy (e.g. relaxation training, hypnosis, anxiety work), with monitoring through ordinary outcome measures and session review. Siever describes pairing AVE with hypnotic suggestion, live or recorded.
• Who delivers it and regulatory status. AVE devices are sold directly to consumers and to clinicians; the Mind Alive manual describes the DAVID Delight as non-invasive (no current passed through the user) and for "wellness", and places responsibility for intake on the health care provider when used clinically. No FDA clearance, Health Canada licence or UK/EU medical-device classification for AVE-only devices, and no…
• Certification. No dedicated professional credential for AVE was identified. Psychotherapists who want a recognised training route in biofeedback or neurofeedback usually look to BCIA certification, but whether BCIA blueprints cover AVE is not verified. Device training is offered by manufacturers; treat it as product training, not a clinical qualification.

Evidence status, as the guide reports it

• Evidence status (as of October 2026, per the sources cited). A 2008 review (Huang and Charyton, Alternative Therapies in Health and Medicine) concluded that brainwave entrainment showed preliminary promise; the University of York's DARE appraisal judged those conclusions "did not appear reliable",…

Questions to explore with your client

• What drew you to it, and what are you hoping it will change?
• Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
• Does it involve intense or unusual breathing? Have you been told about the medical conditions for which that is not advised?
• Is it a group, retreat or community? How do they respond if someone wants to leave or raises a concern?
• How do you and the practitioner understand what is happening, in spiritual or cultural terms? Is that a source of comfort, worry, or both?
• Who runs it, and what training or registration do they hold?
• What actually happens in a session or meeting, and how often?
• What does it cost, and is there pressure to commit to more?
• How do you feel afterwards, in the hours and days that follow?
• Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

• escalating altered-state seeking; substance-use patterns that need their own assessment.
• financial exploitation, guilt in carers who decline, abandonment of established dementia care.
• consent driven by hope after other treatments failed; check the client understands it is optional.
• clients asking you not to tell their doctor; explain why you would not proceed without medical input.
• attributing improvement to the device when therapy or time explain it; sunk-cost reluctance after buying a device.

When to involve someone else

• New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
• Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
• A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.